RBC Capital Markets slashed price targets and cut revenue forecasts for Oxford BioMedica.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
RBC Capital Markets slashed price targets and cut revenue forecasts for Oxford BioMedica.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Oxford BioMedica
bioTech Company
-
RBC Capital Markets
global investment bank
- Financial institutions like RBC and Macquarie maintained 'outperform' ratings amid dashed hopes for a Strait of Hormuz reopening.
- Kratos Defense & Security Solutions filed a shelf registration statement with the SEC, with Robert W. Baird & Co. and RBC Capital Markets acting as joint book-running managers.